Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Augmedix Q4 Sales $6.60M Beat $6.40M Estimate

Augmedix (NASDAQ:AUGX) reported quarterly sales of $6.60 million which beat the analyst consensus estimate of $6.40 million by 3.13 percent.

March 21, 2022

1 minute read

Augmedix (NASDAQ:AUGX) reported quarterly sales of $6.60 million which beat the analyst consensus estimate of $6.40 million by 3.13 percent.

Study Out Of Scotland Shows Risk Of Hospital Admission For Patients With COVID Omicron Variant Reduced By 2/3 vs Delta Variant

Today, 6:13 AM

-Dow Jones

Today, 6:13 AM

-Reuters

Today, 6:13 AM

JP Morgan analyst Cory Kasimov upgrades Ultragenyx Pharmaceutical (NASDAQ:RARE) from Neutral to Overweight and announces $132 price target.

Today, 6:13 AM

JP Morgan analyst Michael Rehaut upgrades Meritage Homes (NYSE:MTH) from Neutral to Overweight and lowers the price target from $158 to $143.